Perelman School of Medicine

Penn Medicine birth marks a milestone in uterus transplant clinical trial

The birth is Penn’s first as part of its uterus transplant clinical trial, and second in the United States following a deceased donor transplant.

One factory worker in a hard hat walking alone on a factory floor.

When automotive assembly plants close, deaths from opioid overdoses rise

A Penn study links eroding economic opportunity to opioid deaths, and builds on previous research that links declining participation in the labor force to increased opioid use in the U.S.

Surprise to some parents, adolescent brains ARE wired for self-control

A Penn study shows developing brain networks support cognition in youth, from decision-making and self-control to complex thought.

The particle accelerator, which sends protons down a beamline as long as a football field through three-story-high gantries, delivers the most cutting-edge proton therapy there is.

Proton therapy lowers risk of side effects in cancer patients

Proton therapy leads to a significantly lower risk of side effects severe enough to lead to unplanned hospitalizations for cancer patients when compared with traditional radiation. Cure rates between the two groups are almost identical.

Amy Gutmann watches as Roderick Wong signs his gift to the Perelman School of Medicine.

A gift for disruption: Visionary Roderick Wong gives back to PennHealthX

Wong, an alum with a medical degree and an MBA, has given Penn Medicine a $6 million gift to endow the Roderick T. Wong PennHealthX Program, one of the largest single gifts to support medical education.

illustration of lungs as a symbol of cystic fibrosis research

A new era in cystic fibrosis treatment

FDA approval of new therapies for cystic fibrosis is a major breakthrough for patients, meaning fewer complications, delayed progression and even longer life expectancies.

nurse in surgery outfit is holding a mammogram in front of x-ray illuminator

Using radiomics to predict breast cancer

Penn researchers can predict 10-year breast cancer recurrence with MRI scans that characterize the genetic makeup of tumors, allowing for individualized, non-invasive treatment.

Lab technician with a sample of plasma blood analyzing the results

Promising findings for multiple myeloma immunotherapy

Adam Cohen of the Perelman School of Medicine headed a clinical trial that found an experimental therapy can make a difference for patients who have exhausted other options.

Engineering the immune system to tackle glioblastoma

Immunotherapy is a “game changer” for improving outcomes in treating Glioblastoma Multiforme, the most common, and most lethal, malignant brain tumor in adults.

Two people sitting on an L-shaped couch amidst four pillows. The one on the right is holding a clipboard.

Side Gigs for Good, part three

The final 2019 installment in our series highlighting impactful work Penn faculty and staff do.

Filters